Gregory Divis

Gregory J.
Divis currently works at Mobius Therapeutics LLC, as Director, Health eVillages, Inc., as Director, Marchem Northeast, Inc., as President, and Avadel Management Corp., as Chief Commercial Officer & Executive VP.
Dr. Divis also formerly worked at AMAG Pharma USA, Inc., as President & Chief Executive Officer from 2011 to 2013, Lumara Health Services Ltd., as President & Chief Executive Officer in 2014, Avadel Pharmaceuticals Plc, as Chief Executive Officer & Director from 2019 to 2026, K-V Generic Pharmaceuticals, Inc., as President, Chief Executive Officer & Director from 2010 to 2014, Accella Performance Materials, Inc., as Director, Tolero Pharmaceuticals, Inc., as Director from 2015 to 2017, Jaguar Health, Inc., as Independent Director from 2018 to 2022, Schering-Plough Corp., as Vice President & General Manager-UK & Ireland from 1992 to 2003, RB Rubber Products, Inc., as President, Linden Manager LLC, as Operating Partner from 2015 to 2016, Sanofi-Aventis U.S.
LLC, as VP-Business Development & Life Cycle Management from 2004 to 2007, and Schering-Plough Ltd., as Principal.
Dr. Divis received his undergraduate degree in 1988 from the University of Iowa.